GRM8
Metabotropic glutamate receptor 8
Also known as: GLUR8, GPRC1H, GRM8_HUMAN, mGlu8, MGLUR8
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00222
- Gene
- GRM8
- Ensembl
- ENSG00000179603
- Chromosome
- 7
- Canonical length
- 908 aa
- Protein class
- G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
908 residues, UniProt reviewed canonical sequence.
>O00222|GRM8
1 MVCEGKRSAS CPCFFLLTAK FYWILTMMQR THSQEYAHSI RVDGDIILGG LFPVHAKGER
61 GVPCGELKKE KGIHRLEAML YAIDQINKDP DLLSNITLGV RILDTCSRDT YALEQSLTFV
121 QALIEKDASD VKCANGDPPI FTKPDKISGV IGAAASSVSI MVANILRLFK IPQISYASTA
181 PELSDNTRYD FFSRVVPPDS YQAQAMVDIV TALGWNYVST LASEGNYGES GVEAFTQISR
241 EIGGVCIAQS QKIPREPRPG EFEKIIKRLL ETPNARAVIM FANEDDIRRI LEAAKKLNQS
301 GHFLWIGSDS WGSKIAPVYQ QEEIAEGAVT ILPKRASIDG FDRYFRSRTL ANNRRNVWFA
361 EFWEENFGCK LGSHGKRNSH IKKCTGLERI ARDSSYEQEG KVQFVIDAVY SMAYALHNMH
421 KDLCPGYIGL CPRMSTIDGK ELLGYIRAVN FNGSAGTPVT FNENGDAPGR YDIFQYQITN
481 KSTEYKVIGH WTNQLHLKVE DMQWAHREHT HPASVCSLPC KPGERKKTVK GVPCCWHCER
541 CEGYNYQVDE LSCELCPLDQ RPNMNRTGCQ LIPIIKLEWH SPWAVVPVFV AILGIIATTF
601 VIVTFVRYND TPIVRASGRE LSYVLLTGIF LCYSITFLMI AAPDTIICSF RRVFLGLGMC
661 FSYAALLTKT NRIHRIFEQG KKSVTAPKFI SPASQLVITF SLISVQLLGV FVWFVVDPPH
721 IIIDYGEQRT LDPEKARGVL KCDISDLSLI CSLGYSILLM VTCTVYAIKT RGVPETFNEA
781 KPIGFTMYTT CIIWLAFIPI FFGTAQSAEK MYIQTTTLTV SMSLSASVSL GMLYMPKVYI
841 IIFHPEQNVQ KRKRSFKAVV TAATMQSKLI QKGNDRPNGE VKSELCESLE TNTSSTKTTY
901 ISYSNHSILocalizationUniProt · AlphaFold · HPA
Whether an antibody against GRM8 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 20 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 20 nTPM
- liver: 2.6 nTPM
- cerebral cortex: 2 nTPM
- rectum: 1.9 nTPM
- retina: 1.8 nTPM
- colon: 1.5 nTPM
Single-cell type
- choroid plexus epithelial cells: 5,167 nCPM
- cardiomyocytes: 1,132 nCPM
- retinal amacrine cells: 855 nCPM
- early spermatids: 322 nCPM
- brain inhibitory neurons: 248 nCPM
- adrenal medulla cells: 245 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 103 nTPM
- pons: 25 nTPM
- midbrain: 22 nTPM
- cerebral cortex: 15 nTPM
- medulla oblongata: 14 nTPM
- hypothalamus: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.91
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway
- adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
- G protein-coupled glutamate receptor signaling pathway
- regulation of synaptic transmission, glutamatergic
- visual perception
Molecular functions
- G protein-coupled receptor activity
- glutamate receptor activity
- group III metabotropic glutamate receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- GPCR, family 3, metabotropic glutamate receptor
- GPCR, family 3
- Receptor, ligand binding region
- GPCR, family 3, nine cysteines domain
- GPCR family 3, C-terminal
- GPCR, family 3, conserved site
- Periplasmic binding protein-like I
- GPCR, family 3, nine cysteines domain superfamily
- Metabotropic Glutamate Receptor
- 7 transmembrane sweet-taste receptor of 3 GCPR
- Receptor family ligand binding region
- Nine Cysteines Domain of family 3 GPCR
- GPCR, family 3, metabotropic glutamate receptor 8
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GRM8 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GRM8 as an antibody target. Whether an autoantibody or antibody against GRM8 could matter depends on whether native GRM8 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GRM8 is annotated at the cell surface, where native GRM8 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GRM8 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...